Skip to Content

Brandes International Equity I BIIEX

Medalist Rating as of | See Brandes Investment Hub
  • NAV / 1-Day Return 20.51  /  +0.49 %
  • Total Assets 777.5 Mil
  • Adj. Expense Ratio
    0.850%
  • Expense Ratio 0.850%
  • Distribution Fee Level Average
  • Share Class Type Institutional
  • Category Foreign Large Value
  • Investment Style Large Value
  • Min. Initial Investment 100,000
  • Status Open
  • TTM Yield 2.54%
  • Turnover 22%

USD | NAV as of Feb 23, 2024 | 1-Day Return as of Feb 23, 2024, 1:15 AM GMT+0

Morningstar’s Analysis BIIEX

Will BIIEX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A strong management team and sound investment process underpin Brandes International Equity I's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BIIEX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 25.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Takeda Pharmaceutical Co Ltd

3.31 25.0 Mil
Healthcare

Rolls-Royce Holdings PLC

3.00 22.7 Mil
Industrials

Heineken Holding NV

2.57 19.4 Mil
Consumer Defensive

Alibaba Group Holding Ltd Ordinary Shares

2.53 19.1 Mil
Consumer Cyclical

Sanofi SA

2.53 19.1 Mil
Healthcare

UBS Group AG

2.53 19.1 Mil
Financial Services

SAP SE

2.29 17.3 Mil
Technology

Heidelberg Materials AG

2.29 17.3 Mil
Basic Materials

Embraer SA ADR

2.27 17.2 Mil
Industrials

GSK PLC

2.13 16.1 Mil
Healthcare